ARCHIVES

SEC Investigating Bristol-Myers’ Sales Statements

This article is from The Cancer Letter archive.

Vol. 28 No. 28 | July 12, 2002

Download PDF Visit The Full Archive

Related Articles

CIS Cost Sharing Feasibility Study Recommended

December 11, 1987

Harkin, Hatfield Introduce Medical Research Trust Fund

March 4, 1994

Tobacco Control: Cigarette Price Hikes Reduce Smoking, Study Confirms

August 7, 1998

In Brief: Doug Ulman named CEO of Pelotonia

September 26, 2014

FDA cancer therapeutics review split among three units in reorganization.

October 10, 2003

FDA’s Commitment To Cancer No Different Than Other Diseases, Kessler Tells Advocate

August 14, 1992